Biology Reference
In-Depth Information
95. Moreau V, Granier C, Villard S,
et al
. (2006) Discontinuous epitope pre-
diction based on mimotope analysis.
Bioinformatics
22
(9): 1088-1095.
96. Scott JK. (1992) Discovering peptide ligands using epitope libraries.
Trends Biochem Sci
17
(7): 241-245.
97. Felici F, Castagnoli L, Musacchio A,
et al
. (1991) Selection of antibody
ligands from a large library of oligopeptides expressed on a multivalent
exposition vector.
J Mol Biol
222
(2): 301-310.
98. Bellofiore P, Petronzelli F, De Martino T,
et al
. (2006) Identification
and refinement of a peptide affinity ligand with unique specificity for a
monoclonal anti-tenascin-C antibody by screening of a phage display
library.
J Chromatogr A
1107
(1-2): 182-191.
99. Dou XG, Talekar G, Chang J,
et al
. (2002) Antigenic heterogeneity of
the hepatitis C virus NS5A protein.
J Clin Microbiol
40
(
1
): 61-67.
100. Biles BD, Connolly BA. (2004) Low-fidelity Pyrococcus furiosus DNA
polymerase mutants useful in error-prone PCR.
Nucleic Acids Res
32
(22): e176.
101. Neylon C. (2004) Chemical and biochemical strategies for the ran-
domization of protein encoding DNA sequences: library construction
methods for directed evolution.
Nucleic Acids Res
32
(4): 1448-1459.
102. Willats WG. (2002) Phage display: practicalities and prospects.
Plant
Mol Biol
50
(6): 837-854.
103. Schooltink H, Rose-John S. (2005) Designing cytokine variants by
phage-display.
Comb Chem High Throughput Screen
8
(2): 173-179.
104. Rothe A, Hosse RJ, Power BE. (2006) Ribosome display for improved
biotherapeutic molecules.
Expert Opin Biol Ther
6
(2): 177-187.
105. Partidos CD, Chirinos-Rojas CL, Steward MW. (1997) The potential
of combinatorial peptide libraries for the identification of inhibitors of
TNF-alpha mediated cytotoxicity
in vitro
.
Immunol Lett
57
(1-3):
113-116.
106. Walden P, Wiesmuller KH, Jung G. (1995) Elucidation of T-cell epi-
topes: a synthetic approach with random peptide libraries.
Biochem Soc
Trans
23
(3): 678-681.
107. Harayama S. (1998) Artificial evolution by DNA shuffling.
Trends
Biotechnol
16
(2): 76-82.
108. Whalen RG, Kaiwar R, Soong NW, Punnonen J. (2001) DNA shuf-
fling and vaccines.
Curr Opin Mol Ther
3
(1): 31-36.
109. Locher CP, Paidhungat M, Whalen RG, Punnonen J. (2005) DNA
shuffling and screening strategies for improving vaccine efficacy.
DNA
Cell Biol
24
(4): 256-263.
